Abstract:It is urgently required to design novel cancer therapies which lead to permanent cancer eradication or cancer control. Oncolytic virotherapy is a promising cancer treatment strategy using genetically engineered viruses which can selectively infect, replicate in and kill tumor cells without harming normal cells. Due to the variable interactions between tumor cells and oncolytic viruses (OVs) as well as the accordingly immune response, the impact of tumor virotherapy on tumor control is prominent. We propose a novel mathematical modeling framework based on delay differential equation to study tumor virotherapy with mediated antitumor immunity by OVs, which incorporates complex tumor–virus–immune system interactions. We initially study the existence and local stability of equilibria, and theoretically and numerically investigate the local Hopf bifurcation from the positive equilibrium by considering the time delay as a bifurcation parameter. Further, we analyze the direction of Hopf bifurcation and the stability of bifurcating periodic solution. Main results show that the time delay can induce Hopf bifurcation and result in periodic oscillations, indicating that the delayed tumor-specific CTL response induced by OVs leads to complex dynamics and may significantly influence the development process of tumor growth. Our findings also provide insight into important aspects of the virotherapy, including the dependence of the efficacy on key factors. We find that enhancing the induction of antitumor immunity by OVs can reduce the complexity of dynamics by strengthening the stability and show considerable effects on combating tumor. Further, proper choice of OVs with relative strong ability to lyse tumor cells is beneficial to ultimately control the development process of tumor growth.

Bistability and chaotic behaviors in a 4D cancer oncolytic virotherapy mathematical model: Pspice and FPGA implementations

Oscillations in a Spatial Oncolytic Virus Model

Modeling the Virus-Induced Tumor-Specific Immune Response with Delay in Tumor Virotherapy.

Finding Hopf bifurcation islands and identifying thresholds for success or failure in oncolytic viral therapy

Oncolytic virotherapy for tumours following a Gompertz growth law

Hopf bifurcation analysis of a tumor virotherapy model with two time delays

Hopf bifurcation and normal form in a delayed oncolytic model

Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis

The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study

Backward Hopf Bifurcation In A Mathematical Model For Oncolytic Virotherapy With The Infection Delay And Innate Immune Effects

Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols

Modeling oncolytic virus therapy with distributed delay and non-local diffusion

Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics

On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: Insights from a mathematical model

Modeling dynamics of cancer radiovirotherapy

Spatiotemporal spread of oncolytic virus in a heterogeneous cell population

A general non-local delay model on oncolytic virus therapy

Mathematical modeling of anti-tumor virus therapy: Regimes with complete recovery within the framework of deterministic models

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

Questing for an optimal, universal viral agent for oncolytic virotherapy